CSat Investment Advisory’s Repligen RGEN Stock Holding History

CSat Investment Advisory’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-343	Closed	-$51K	–	861
2020 Q3	$51K	Buy	343 +41	+14%	+$5.86K	﹤0.01%	667
2020 Q2	$37K	Buy	+302	New	+$35.5K	﹤0.01%	716

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

CSat Investment Advisory's RGEN Position: Q4 2020 in Review

CSat Investment Advisory sold out of Repligen (RGEN) in Q4 2020, closing a stake of 343 shares — an estimated $51K sold.

CSat Investment Advisory first reported a position in RGEN in Q2 2020 and held it in 2 quarters. The position peaked at $51K in Q3 2020. 449 funds tracked by Wall St. Rank hold RGEN as of Q4 2020.

CSat Investment Advisory reported no remaining Repligen position as of Q4 2020 after selling out during the quarter.
CSat Investment Advisory sold 343 Repligen shares in Q4 2020, an estimated $51K.
CSat Investment Advisory first reported a position in Repligen in Q2 2020 and held it in 2 quarters.
CSat Investment Advisory's Repligen position peaked at $51K in Q3 2020.
449 funds tracked by Wall St. Rank held Repligen as of Q4 2020.

Based on CSat Investment Advisory's 13F filing for Q4 2020, filed 12 Feb 2021.